Description

🧬 Overview

PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin analogues. Unlike traditional approaches that target vascular pathways, PT-141 acts directly on the central nervous system. It has become a key focus in research related to sexual health, arousal mechanisms, and neurochemical signaling.

⚙️ Technical Profile

• Peptide Name: PT-141 (Bremelanotide)
• Type: Synthetic melanocortin receptor agonist
• Sequence Length: 7 amino acids
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: ~1025.2 g/mol
• Structure: Cyclic peptide
• Target Receptors: MC3R and MC4R
• Biological Role: CNS-mediated arousal and signaling
• Purity (Research Grade): Typically ≥98%
• Form: Lyophilized powder / nasal spray (research use)
• Solubility: Water-soluble

⚡ Mechanism of Action

PT-141 works by activating melanocortin receptors in the central nervous system, particularly MC3R and MC4R. These receptors are involved in regulating sexual arousal and behavioral responses.

Unlike compounds that rely on blood flow mechanisms, PT-141 influences neural pathways directly, modulating neurotransmitter activity associated with desire and response.

This central mechanism differentiates it from other compounds studied in sexual health research.

🔬 Research Context

PT-141 has been extensively studied in research related to sexual health and neurobiology. It is commonly explored for its potential to influence libido, arousal, and behavioral responses in both male and female models.

Research also investigates its broader neurological effects due to its interaction with melanocortin pathways. Its unique CNS-based mechanism makes it a significant compound in advanced peptide and neuroendocrine research.

Ongoing studies continue to evaluate its applications in sexual health and behavioral science.